Dr. Ryan C. Baker, M.D.
Urology (Urology Physician)
221 W. Colorado Blvd., Methodist Pavillion Ii, Suite 940
Dallas, TX 75208
- Medicare participating
At a glance
- Medical school
- University of Oklahoma College of Medicine (2016)
- Years since graduation
- 10
- In the NPI registry since
- 2016
- Medicare patients seen, 2024
- 252
Licensed in Texas since 2021, according to the Texas Medical Board. We show license dates only for the states that publish them in bulk; see which states do. For other states, check the state medical board.
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. What an NPI is
Education and training
- 2016Medical school: University of Oklahoma College of Medicine
- 2016Registered with an NPI (national billing number; not a license date)
Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Urology Physician primary
TX license T1000 (first issued 2021; active) -
Student in an Organized Health Care Education/Training Program
TX license BP10058193
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- Methodist Dallas Medical Center Dallas, TX
Medical groups
- Urology Clinics of North Texas, PLLC (73 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 252
- Services billed
- 2,412
- Patients’ average age
- 70
| Service | Times | Patients |
|---|---|---|
| Automated urinalysis test | 225 | 138 |
| Detection test by nucleic acid for organism, amplified probe technique | 208 | 15 |
| Established patient office or other outpatient visit, 30-39 minutes | 163 | 89 |
| Established patient office or other outpatient visit, 20-29 minutes | 107 | 77 |
| Bacterial colony count, urine | 105 | 73 |
| Ultrasound measurement of bladder capacity after voiding | 105 | 74 |
| Injection, ceftriaxone sodium, per 250 mg | 100 | 25 |
| Insertion of needle into vein for collection of blood sample | 89 | 58 |
| Bacterial urine culture | 85 | 44 |
| New patient office or other outpatient visit, 45-59 minutes | 70 | 70 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Tamsulosin Hcl Other prescribers in Dallas, TX | 370 |
| Finasteride Other prescribers in Dallas, TX | 221 |
| Orgovyx (relugolix) | 131 |
| Ciprofloxacin Hcl Other prescribers in Dallas, TX | 117 |
| Gemtesa (vibegron) Other prescribers in Dallas, TX | 104 |
| Xtandi (enzalutamide) | 94 |
| Myrbetriq (mirabegron) Other prescribers in Dallas, TX | 72 |
| Amoxicillin-Clavulanate Potass (amoxicillin/potassium clav) Other prescribers in Dallas, TX | 56 |
| Tramadol Hcl Other prescribers in Dallas, TX | 47 |
| Oxybutynin Chloride Er (oxybutynin chloride) Other prescribers in Dallas, TX | 41 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 27 companies reported 76 payments worth $1,781 in total to this clinician.
| Janssen Biotech, Inc. | $411 |
|---|---|
| Sumitomo Pharma America, Inc. | $270 |
| Tempus Ai, Inc | $115 |
| Bayer HealthCare Pharmaceuticals Inc. | $104 |
| Dendreon Pharmaceuticals LLC | $89.59 |
| Medtronic, Inc. | $69.62 |
| Astellas Pharma US Inc | $69.40 |
| Novartis Pharmaceuticals Corporation | $58.49 |
| Food and Beverage | $1,746 |
|---|---|
| Education | $35.06 |
What the payments were for
| Company | What it was for | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP Nov 19, 2025 | Education IMFINZI · Oncology · in-kind Company’s descriptionJournal Article | $35.06 |
Each payment as the company reported it, with the products it named. Meals are counted in the totals above but not listed one by one.
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.